 | • レポートコード：MRC2-11QY05749 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は上衣腫治療薬のグローバル市場について調査・分析したレポートです。種類別（アベマシクリブ、インドキシモド、ジマレイン酸アファチニブ、アリセルチブ、G-207、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別上衣腫治療薬の競争状況、市場シェア ・世界の上衣腫治療薬市場：種類別市場規模 2015年-2020年（アベマシクリブ、インドキシモド、ジマレイン酸アファチニブ、アリセルチブ、G-207、その他） ・世界の上衣腫治療薬市場：種類別市場規模予測 2021年-2026年（アベマシクリブ、インドキシモド、ジマレイン酸アファチニブ、アリセルチブ、G-207、その他） ・世界の上衣腫治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界の上衣腫治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米の上衣腫治療薬市場分析：米国、カナダ ・ヨーロッパの上衣腫治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの上衣腫治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の上衣腫治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの上衣腫治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Cavion LLC、Advantagene Inc、Amgen Inc、Celgene Corp、Eli Lilly and Company、Millennium Pharmaceuticals Inc、NewLink Genetics Corp、Ono Pharmaceutical Co Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Ependymoma Drug Market
The global Ependymoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Ependymoma Drug Scope and Market Size
Ependymoma Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ependymoma Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Ependymoma Drug market is segmented into
Abemaciclib
Indoximod
Afatinib Dimaleate
Alisertib
G-207
Others
Segment by Application, the Ependymoma Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Ependymoma Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ependymoma Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ependymoma Drug Market Share Analysis
Ependymoma Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ependymoma Drug business, the date to enter into the Ependymoma Drug market, Ependymoma Drug product introduction, recent developments, etc.
The major vendors covered:
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Cavion LLC
Advantagene Inc
Amgen Inc
Celgene Corp
Eli Lilly and Company
Millennium Pharmaceuticals Inc
NewLink Genetics Corp
Ono Pharmaceutical Co Ltd
1 Study Coverage
1.1 Ependymoma Drug Product Introduction
1.2 Market Segments
1.3 Key Ependymoma Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Ependymoma Drug Market Size Growth Rate by Type
1.4.2 Abemaciclib
1.4.3 Indoximod
1.4.4 Afatinib Dimaleate
1.4.5 Alisertib
1.4.6 G-207
1.4.7 Others
1.5 Market by Application
1.5.1 Global Ependymoma Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ependymoma Drug Market Size, Estimates and Forecasts
2.1.1 Global Ependymoma Drug Revenue 2015-2026
2.1.2 Global Ependymoma Drug Sales 2015-2026
2.2 Global Ependymoma Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Ependymoma Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Ependymoma Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Ependymoma Drug Competitor Landscape by Players
3.1 Ependymoma Drug Sales by Manufacturers
3.1.1 Ependymoma Drug Sales by Manufacturers (2015-2020)
3.1.2 Ependymoma Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Ependymoma Drug Revenue by Manufacturers
3.2.1 Ependymoma Drug Revenue by Manufacturers (2015-2020)
3.2.2 Ependymoma Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Ependymoma Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Ependymoma Drug Revenue in 2019
3.2.5 Global Ependymoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Ependymoma Drug Price by Manufacturers
3.4 Ependymoma Drug Manufacturing Base Distribution, Product Types
3.4.1 Ependymoma Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ependymoma Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ependymoma Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ependymoma Drug Market Size by Type (2015-2020)
4.1.1 Global Ependymoma Drug Sales by Type (2015-2020)
4.1.2 Global Ependymoma Drug Revenue by Type (2015-2020)
4.1.3 Ependymoma Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Ependymoma Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Ependymoma Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Ependymoma Drug Revenue Forecast by Type (2021-2026)
4.2.3 Ependymoma Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Ependymoma Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Ependymoma Drug Market Size by Application (2015-2020)
5.1.1 Global Ependymoma Drug Sales by Application (2015-2020)
5.1.2 Global Ependymoma Drug Revenue by Application (2015-2020)
5.1.3 Ependymoma Drug Price by Application (2015-2020)
5.2 Ependymoma Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Ependymoma Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Ependymoma Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Ependymoma Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Ependymoma Drug by Country
6.1.1 North America Ependymoma Drug Sales by Country
6.1.2 North America Ependymoma Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Ependymoma Drug Market Facts & Figures by Type
6.3 North America Ependymoma Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Ependymoma Drug by Country
7.1.1 Europe Ependymoma Drug Sales by Country
7.1.2 Europe Ependymoma Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ependymoma Drug Market Facts & Figures by Type
7.3 Europe Ependymoma Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Ependymoma Drug by Region
8.1.1 Asia Pacific Ependymoma Drug Sales by Region
8.1.2 Asia Pacific Ependymoma Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Ependymoma Drug Market Facts & Figures by Type
8.3 Asia Pacific Ependymoma Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Ependymoma Drug by Country
9.1.1 Latin America Ependymoma Drug Sales by Country
9.1.2 Latin America Ependymoma Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Ependymoma Drug Market Facts & Figures by Type
9.3 Central & South America Ependymoma Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Ependymoma Drug by Country
10.1.1 Middle East and Africa Ependymoma Drug Sales by Country
10.1.2 Middle East and Africa Ependymoma Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Ependymoma Drug Market Facts & Figures by Type
10.3 Middle East and Africa Ependymoma Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Description and Business Overview
11.1.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim GmbH Ependymoma Drug Products Offered
11.1.5 Boehringer Ingelheim GmbH Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company Ependymoma Drug Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 Cavion LLC
11.3.1 Cavion LLC Corporation Information
11.3.2 Cavion LLC Description and Business Overview
11.3.3 Cavion LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Cavion LLC Ependymoma Drug Products Offered
11.3.5 Cavion LLC Related Developments
11.4 Advantagene Inc
11.4.1 Advantagene Inc Corporation Information
11.4.2 Advantagene Inc Description and Business Overview
11.4.3 Advantagene Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Advantagene Inc Ependymoma Drug Products Offered
11.4.5 Advantagene Inc Related Developments
11.5 Amgen Inc
11.5.1 Amgen Inc Corporation Information
11.5.2 Amgen Inc Description and Business Overview
11.5.3 Amgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Inc Ependymoma Drug Products Offered
11.5.5 Amgen Inc Related Developments
11.6 Celgene Corp
11.6.1 Celgene Corp Corporation Information
11.6.2 Celgene Corp Description and Business Overview
11.6.3 Celgene Corp Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Celgene Corp Ependymoma Drug Products Offered
11.6.5 Celgene Corp Related Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Corporation Information
11.7.2 Eli Lilly and Company Description and Business Overview
11.7.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company Ependymoma Drug Products Offered
11.7.5 Eli Lilly and Company Related Developments
11.8 Millennium Pharmaceuticals Inc
11.8.1 Millennium Pharmaceuticals Inc Corporation Information
11.8.2 Millennium Pharmaceuticals Inc Description and Business Overview
11.8.3 Millennium Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Millennium Pharmaceuticals Inc Ependymoma Drug Products Offered
11.8.5 Millennium Pharmaceuticals Inc Related Developments
11.9 NewLink Genetics Corp
11.9.1 NewLink Genetics Corp Corporation Information
11.9.2 NewLink Genetics Corp Description and Business Overview
11.9.3 NewLink Genetics Corp Sales, Revenue and Gross Margin (2015-2020)
11.9.4 NewLink Genetics Corp Ependymoma Drug Products Offered
11.9.5 NewLink Genetics Corp Related Developments
11.10 Ono Pharmaceutical Co Ltd
11.10.1 Ono Pharmaceutical Co Ltd Corporation Information
11.10.2 Ono Pharmaceutical Co Ltd Description and Business Overview
11.10.3 Ono Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ono Pharmaceutical Co Ltd Ependymoma Drug Products Offered
11.10.5 Ono Pharmaceutical Co Ltd Related Developments
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Corporation Information
11.1.2 Boehringer Ingelheim GmbH Description and Business Overview
11.1.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Boehringer Ingelheim GmbH Ependymoma Drug Products Offered
11.1.5 Boehringer Ingelheim GmbH Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Ependymoma Drug Market Estimates and Projections by Region
12.1.1 Global Ependymoma Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Ependymoma Drug Revenue Forecast by Regions 2021-2026
12.2 North America Ependymoma Drug Market Size Forecast (2021-2026)
12.2.1 North America: Ependymoma Drug Sales Forecast (2021-2026)
12.2.2 North America: Ependymoma Drug Revenue Forecast (2021-2026)
12.2.3 North America: Ependymoma Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Ependymoma Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Ependymoma Drug Sales Forecast (2021-2026)
12.3.2 Europe: Ependymoma Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Ependymoma Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Ependymoma Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Ependymoma Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Ependymoma Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Ependymoma Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Ependymoma Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Ependymoma Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Ependymoma Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Ependymoma Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Ependymoma Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Ependymoma Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Ependymoma Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Ependymoma Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Ependymoma Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ependymoma Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Ependymoma Drug Market Segments
Table 2. Ranking of Global Top Ependymoma Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Ependymoma Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Abemaciclib
Table 5. Major Manufacturers of Indoximod
Table 6. Major Manufacturers of Afatinib Dimaleate
Table 7. Major Manufacturers of Alisertib
Table 8. Major Manufacturers of G-207
Table 9. Major Manufacturers of Others
Table 10. Global Ependymoma Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Ependymoma Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Ependymoma Drug Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Ependymoma Drug Sales Market Share by Regions (2015-2020)
Table 14. Global Ependymoma Drug Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Ependymoma Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Ependymoma Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Ependymoma Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Ependymoma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ependymoma Drug as of 2019)
Table 19. Ependymoma Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Ependymoma Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Ependymoma Drug Price (2015-2020) (USD/Pcs)
Table 22. Ependymoma Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Ependymoma Drug Product Type
Table 24. Date of International Manufacturers Enter into Ependymoma Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Ependymoma Drug Sales Share by Type (2015-2020)
Table 28. Global Ependymoma Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Ependymoma Drug Revenue Share by Type (2015-2020)
Table 30. Ependymoma Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 32. Global Ependymoma Drug Sales Share by Application (2015-2020)
Table 33. North America Ependymoma Drug Sales by Country (2015-2020) (K Pcs)
Table 34. North America Ependymoma Drug Sales Market Share by Country (2015-2020)
Table 35. North America Ependymoma Drug Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Ependymoma Drug Revenue Market Share by Country (2015-2020)
Table 37. North America Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 38. North America Ependymoma Drug Sales Market Share by Type (2015-2020)
Table 39. North America Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 40. North America Ependymoma Drug Sales Market Share by Application (2015-2020)
Table 41. Europe Ependymoma Drug Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Ependymoma Drug Sales Market Share by Country (2015-2020)
Table 43. Europe Ependymoma Drug Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Ependymoma Drug Revenue Market Share by Country (2015-2020)
Table 45. Europe Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Ependymoma Drug Sales Market Share by Type (2015-2020)
Table 47. Europe Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Ependymoma Drug Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Ependymoma Drug Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Ependymoma Drug Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Ependymoma Drug Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Ependymoma Drug Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Ependymoma Drug Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Ependymoma Drug Sales Market Share by Application (2015-2020)
Table 57. Latin America Ependymoma Drug Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Ependymoma Drug Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Ependymoma Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Ependymoma Drug Revenue Market Share by Country (2015-2020)
Table 61. Latin America Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Ependymoma Drug Sales Market Share by Type (2015-2020)
Table 63. Latin America Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Ependymoma Drug Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Ependymoma Drug Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Ependymoma Drug Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Ependymoma Drug Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Ependymoma Drug Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Ependymoma Drug Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Ependymoma Drug Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Ependymoma Drug Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Ependymoma Drug Sales Market Share by Application (2015-2020)
Table 73. Boehringer Ingelheim GmbH Corporation Information
Table 74. Boehringer Ingelheim GmbH Description and Major Businesses
Table 75. Boehringer Ingelheim GmbH Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Boehringer Ingelheim GmbH Product
Table 77. Boehringer Ingelheim GmbH Recent Development
Table 78. Bristol-Myers Squibb Company Corporation Information
Table 79. Bristol-Myers Squibb Company Description and Major Businesses
Table 80. Bristol-Myers Squibb Company Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Bristol-Myers Squibb Company Product
Table 82. Bristol-Myers Squibb Company Recent Development
Table 83. Cavion LLC Corporation Information
Table 84. Cavion LLC Description and Major Businesses
Table 85. Cavion LLC Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Cavion LLC Product
Table 87. Cavion LLC Recent Development
Table 88. Advantagene Inc Corporation Information
Table 89. Advantagene Inc Description and Major Businesses
Table 90. Advantagene Inc Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Advantagene Inc Product
Table 92. Advantagene Inc Recent Development
Table 93. Amgen Inc Corporation Information
Table 94. Amgen Inc Description and Major Businesses
Table 95. Amgen Inc Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Amgen Inc Product
Table 97. Amgen Inc Recent Development
Table 98. Celgene Corp Corporation Information
Table 99. Celgene Corp Description and Major Businesses
Table 100. Celgene Corp Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Celgene Corp Product
Table 102. Celgene Corp Recent Development
Table 103. Eli Lilly and Company Corporation Information
Table 104. Eli Lilly and Company Description and Major Businesses
Table 105. Eli Lilly and Company Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Eli Lilly and Company Product
Table 107. Eli Lilly and Company Recent Development
Table 108. Millennium Pharmaceuticals Inc Corporation Information
Table 109. Millennium Pharmaceuticals Inc Description and Major Businesses
Table 110. Millennium Pharmaceuticals Inc Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Millennium Pharmaceuticals Inc Product
Table 112. Millennium Pharmaceuticals Inc Recent Development
Table 113. NewLink Genetics Corp Corporation Information
Table 114. NewLink Genetics Corp Description and Major Businesses
Table 115. NewLink Genetics Corp Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. NewLink Genetics Corp Product
Table 117. NewLink Genetics Corp Recent Development
Table 118. Ono Pharmaceutical Co Ltd Corporation Information
Table 119. Ono Pharmaceutical Co Ltd Description and Major Businesses
Table 120. Ono Pharmaceutical Co Ltd Ependymoma Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Ono Pharmaceutical Co Ltd Product
Table 122. Ono Pharmaceutical Co Ltd Recent Development
Table 123. Global Ependymoma Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 124. Global Ependymoma Drug Sales Market Share Forecast by Regions (2021-2026)
Table 125. Global Ependymoma Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 126. Global Ependymoma Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 127. North America: Ependymoma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. North America: Ependymoma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Europe: Ependymoma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Europe: Ependymoma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Asia Pacific: Ependymoma Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 132. Asia Pacific: Ependymoma Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 133. Latin America: Ependymoma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 134. Latin America: Ependymoma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Middle East and Africa: Ependymoma Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Middle East and Africa: Ependymoma Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 138. Key Challenges
Table 139. Market Risks
Table 140. Main Points Interviewed from Key Ependymoma Drug Players
Table 141. Ependymoma Drug Customers List
Table 142. Ependymoma Drug Distributors List
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Ependymoma Drug Product Picture
Figure 2. Global Ependymoma Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Abemaciclib Product Picture
Figure 4. Indoximod Product Picture
Figure 5. Afatinib Dimaleate Product Picture
Figure 6. Alisertib Product Picture
Figure 7. G-207 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Ependymoma Drug Sales Market Share by Application in 2020 & 2026
Figure 10. Clinic
Figure 11. Hospital
Figure 12. Others
Figure 13. Ependymoma Drug Report Years Considered
Figure 14. Global Ependymoma Drug Market Size 2015-2026 (US$ Million)
Figure 15. Global Ependymoma Drug Sales 2015-2026 (K Pcs)
Figure 16. Global Ependymoma Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Ependymoma Drug Sales Market Share by Region (2015-2020)
Figure 18. Global Ependymoma Drug Sales Market Share by Region in 2019
Figure 19. Global Ependymoma Drug Revenue Market Share by Region (2015-2020)
Figure 20. Global Ependymoma Drug Revenue Market Share by Region in 2019
Figure 21. Global Ependymoma Drug Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Ependymoma Drug Revenue in 2019
Figure 23. Ependymoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Ependymoma Drug Sales Market Share by Type (2015-2020)
Figure 25. Global Ependymoma Drug Sales Market Share by Type in 2019
Figure 26. Global Ependymoma Drug Revenue Market Share by Type (2015-2020)
Figure 27. Global Ependymoma Drug Revenue Market Share by Type in 2019
Figure 28. Global Ependymoma Drug Market Share by Price Range (2015-2020)
Figure 29. Global Ependymoma Drug Sales Market Share by Application (2015-2020)
Figure 30. Global Ependymoma Drug Sales Market Share by Application in 2019
Figure 31. Global Ependymoma Drug Revenue Market Share by Application (2015-2020)
Figure 32. Global Ependymoma Drug Revenue Market Share by Application in 2019
Figure 33. North America Ependymoma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Ependymoma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Ependymoma Drug Sales Market Share by Country in 2019
Figure 36. North America Ependymoma Drug Revenue Market Share by Country in 2019
Figure 37. U.S. Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Ependymoma Drug Market Share by Type in 2019
Figure 42. North America Ependymoma Drug Market Share by Application in 2019
Figure 43. Europe Ependymoma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Ependymoma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Ependymoma Drug Sales Market Share by Country in 2019
Figure 46. Europe Ependymoma Drug Revenue Market Share by Country in 2019
Figure 47. Germany Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Ependymoma Drug Market Share by Type in 2019
Figure 58. Europe Ependymoma Drug Market Share by Application in 2019
Figure 59. Asia Pacific Ependymoma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Ependymoma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Ependymoma Drug Sales Market Share by Region in 2019
Figure 62. Asia Pacific Ependymoma Drug Revenue Market Share by Region in 2019
Figure 63. China Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Ependymoma Drug Market Share by Type in 2019
Figure 86. Asia Pacific Ependymoma Drug Market Share by Application in 2019
Figure 87. Latin America Ependymoma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Ependymoma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Ependymoma Drug Sales Market Share by Country in 2019
Figure 90. Latin America Ependymoma Drug Revenue Market Share by Country in 2019
Figure 91. Mexico Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Ependymoma Drug Market Share by Type in 2019
Figure 98. Latin America Ependymoma Drug Market Share by Application in 2019
Figure 99. Middle East and Africa Ependymoma Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Ependymoma Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Ependymoma Drug Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Ependymoma Drug Revenue Market Share by Country in 2019
Figure 103. Turkey Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Ependymoma Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Ependymoma Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Ependymoma Drug Market Share by Type in 2019
Figure 110. Middle East and Africa Ependymoma Drug Market Share by Application in 2019
Figure 111. North America Ependymoma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Ependymoma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Ependymoma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Ependymoma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Ependymoma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Ependymoma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Ependymoma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Ependymoma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Ependymoma Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Ependymoma Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
上衣腫の世界市場（～2026年） Ependymoma are tissue-based tumors arising from the cells lining the ventricles and central canal within the spinal cord. Like many tumor types, the exact cause of ependymoma is not known. Unknown causes and lucrative revenue prospects have grabbed attention from big drug makers and thus the market …- 髄膜腫治療薬の世界市場（～2026年） Market Analysis and Insights: Global Meningioma Drug Market The global Meningioma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Meningioma Drug Scope and Market Size Meningioma Drug market is segmented by Type, …
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- ポンチングリオーマ治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pontine Glioma Drug Market The global Pontine Glioma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Pontine Glioma Drug Scope and Market Size Pontine Glioma Drug market is seg…
- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…